好事达(ALL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALL 好事达

未开盘 05-06 16:00:00 EDT

170.08

+1.90

+1.13%

盘后170.08

+0.000.00%

17:08 EDT

最高170.86	最低168.85	成交量118.33万
今开169.52	昨收168.18	日振幅1.20%
总市值448.87亿	流通市值445.56亿	总股本2.64亿
成交额2.01亿	换手率0.45%	流通股本2.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALL","market":"US","secType":"STK","nameCN":"好事达","latestPrice":170.08,"timestamp":1715025600000,"preClose":168.18,"halted":0,"volume":1183266,"hourTrading":{"tag":"盘后","latestPrice":170.08,"preClose":170.08,"latestTime":"17:08 EDT","volume":48703,"amount":8283340.32,"timestamp":1715029702044},"delay":0,"floatShares":261971833,"shares":263915332,"eps":4.629724,"marketStatus":"未开盘","marketStatusCode":0,"change":1.9,"latestTime":"05-06 16:00:00 EDT","open":169.52,"high":170.86,"low":168.85,"amount":200773226.23722,"amplitude":0.011951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.629724,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715068800000},"adr":0,"listingDate":739080000000,"adjPreClose":168.18,"adrRate":0,"dividendRate":0.021108,"preHourTrading":{"tag":"盘前","latestPrice":169.99,"preClose":168.18,"latestTime":"09:03 EDT","volume":151,"amount":25619.99031,"timestamp":1715000589117},"postHourTrading":{"tag":"盘后","latestPrice":170.08,"preClose":170.08,"latestTime":"17:08 EDT","volume":48703,"amount":8283340.32,"timestamp":1715029702044},"volumeRatio":0.664186},"requestUrl":"/m/hq/s/ALL/","defaultTab":"news","newsList":[{"id":"2433434878","title":"好事达2024财年第一财季实现净利润12.18亿美元，同比增加480.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433434878","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433434878?lang=zh_cn&edition=full","pubTime":"2024-05-06 00:25","pubTimestamp":1714926329,"startTime":"0","endTime":"0","summary":"3月31日，好事达公布财报，公告显示公司2024财年第一财季净利润为12.18亿美元，同比增加480.63%；其中营业收入为152.59亿美元，同比增加10.68%，每股基本收益为4.51美元。从资产负债表来看，好事达总负债780.35亿美元，其中短期债务6.00亿美元，资产负债比为1.24，流动比率为0.46。机构评级：截至2024年3月31日，当前有16家机构对好事达目标价做出预测，其中目标均价为189.88美元，其中最低目标价为146.00美元，最高目标价为206.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405060025418b76cd2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405060025418b76cd2e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432598614","title":"小摩：维持Allstate(ALL.US)评级，由增持调整至增持评级, 目标价由185.00美元调整至193.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432598614","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432598614?lang=zh_cn&edition=full","pubTime":"2024-05-02 23:25","pubTimestamp":1714663547,"startTime":"0","endTime":"0","summary":"小摩：维持Allstate(ALL.US)评级，由增持调整至增持评级, 目标价由185.00美元调整至193.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022325478b6d6c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405022325478b6d6c5e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432030246","title":"美国研究综述-万事达卡、Metagenomi、Ziff Davis","url":"https://stock-news.laohu8.com/highlight/detail?id=2432030246","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432030246?lang=zh_cn&edition=full","pubTime":"2024-05-02 20:59","pubTimestamp":1714654793,"startTime":"0","endTime":"0","summary":"    路透5月2日 - 华尔街证券分析师周四调整了对万事达卡、Metagenomi 和 Ziff Davis 等几家美国上市公司的评级和目标价。* 万事达卡公司  ：摩根大通将目标价从520美元下调至510美元 * Metagenomi Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426735069","title":"由于保单需求强劲，Progressive 盈利超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2426735069","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426735069?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:38","pubTimestamp":1712932687,"startTime":"0","endTime":"0","summary":"    路透社4月12日 - 保险公司 Progressive Corp    周五公布的第一季度利润好于预期，这得益于对其个人和财产保险的强劲需求，使其股价在早盘交易中上涨了 2%。强劲的就业市场和工资上涨推动了汽车保险消费的恢复，而汽车保险是 Progressive 的核心业务之一。今年迄今为止，Progressive 的股价已经上涨了 30%，超过了 Allstate    和 Travelers    等同行，后者的涨幅分别为 20% 和 17%。Progressive 的净保费收入为 161.5 亿美元，比去年高出 19%。综合比率低于 100%，意味着保险公司的保费收入高于赔付金额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426686772","title":"Evercore ISI Group：维持Allstate(ALL.US)评级，由大市同步调整至大市同步评级, 目标价由166.00美元调整至173.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426686772","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426686772?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:45","pubTimestamp":1712843136,"startTime":"0","endTime":"0","summary":"Evercore ISI Group：维持Allstate(ALL.US)评级，由大市同步调整至大市同步评级, 目标价由166.00美元调整至173.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112145388b109d70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112145388b109d70&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426418773","title":"Keefe, Bruyette & Woods：维持Allstate(ALL.US)评级，由优于大市调整至优于大市评级, 目标价由181.00美元调整至189.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426418773","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426418773?lang=zh_cn&edition=full","pubTime":"2024-04-10 22:15","pubTimestamp":1712758531,"startTime":"0","endTime":"0","summary":"Keefe, Bruyette & Woods：维持Allstate(ALL.US)评级，由优于大市调整至优于大市评级, 目标价由181.00美元调整至189.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102215318761a2fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102215318761a2fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425976997","title":"Roth MKM：重申Allstate(ALL.US)评级，由买入调整至买入评级, 目标价由175.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2425976997","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425976997?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:25","pubTimestamp":1712582755,"startTime":"0","endTime":"0","summary":"Roth MKM：重申Allstate(ALL.US)评级，由买入调整至买入评级, 目标价由175.00美元调整至200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082125578afeb9a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082125578afeb9a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422916609","title":"亚盛医药2023年业绩：商业化能力持续增强，全球临床开发迎收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2422916609","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2422916609?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:34","pubTimestamp":1711550040,"startTime":"0","endTime":"0","summary":"报告期内，公司在商业化自我造血能力持续提升的同时，快速推进以患者为中心的\"全球创新\"战略，在临床开发及国际化布局等方面均获得里程碑式进展。亚盛医药的商业化自我造血能力也在持续增强。此外，亚盛医药也在同步深耕APG-2575在血液肿瘤领域的临床布局，在报告期内斩获了3项全球注册III期临床研究。截至2023年12月31日，公司在全球拥有498项授权专利，其中352项专利为海外授权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4372556_ZH72556_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420427047","title":"Allogene Therapeutics, Inc.盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420427047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420427047?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:50","pubTimestamp":1710867011,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时50分，Allogene Therapeutics, Inc.股票出现波动，股价快速上涨5.13%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为899.72%、427.39%、391.51%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Scisparc Ltd.，振幅分别为82.59%、75.79%、72.84%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320005012791b7d2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320005012791b7d2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420724584","title":"Allogene Therapeutics, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420724584","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420724584?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:42","pubTimestamp":1710769340,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时42分，Allogene Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为63.18%、12.33%、9.47%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Immuneering Corporation、Elicio Therapeutics, Inc.，振幅分别为23.07%、23.04%、16.20%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182142217a4d6f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403182142217a4d6f9b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419744569","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅拉升5.23%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419744569","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419744569?lang=zh_cn&edition=full","pubTime":"2024-03-15 21:31","pubTimestamp":1710509500,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日21时31分，Allogene Therapeutics, Inc.股票出现异动，股价大幅拉升5.23%。截至发稿，该股报4.73美元/股，成交量15.0805万股，换手率0.09%，振幅0.33%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Better Therapeutics, Inc.、杰龙、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Kintara Therapeutics, Inc.较为活跃，换手率分别为124.67%、57.89%、10.29%，振幅较大的相关个股有Better Therapeutics, Inc.、联拓生物、Tracon Pharmaceuticals, Inc.，振幅分别为18.00%、14.17%、13.07%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213140791adaa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240315213140791adaa8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419760218","title":"Allogene Therapeutics, Inc.盘中异动 快速下挫5.53%报4.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419760218","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419760218?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:38","pubTimestamp":1710423514,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时38分，Allogene Therapeutics, Inc.股票出现异动，股价大幅下挫5.53%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Nutriband Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.、First Wave Biopharma, Inc.较为活跃，换手率分别为125.17%、62.01%、52.03%，振幅较大的相关个股有Nuvectis Pharma, Inc.、Nutriband Inc C/Wts 、Coherus Biosciences, Inc.，振幅分别为24.38%、19.20%、16.30%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213834791a7beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314213834791a7beb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418067875","title":"Allogene Therapeutics, Inc.盘中异动 大幅跳水5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418067875","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418067875?lang=zh_cn&edition=full","pubTime":"2024-03-09 01:16","pubTimestamp":1709918166,"startTime":"0","endTime":"0","summary":"北京时间2024年03月09日01时16分，Allogene Therapeutics, Inc.股票出现波动，股价急速下挫5.21%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。消息层面，截至01时16分，《Allogene TherapeuticsParker Geoffrey M.增持190股普通股股份，价值约683.05美元》资讯为影响Allogene Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030901160687e775f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030901160687e775f4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417912609","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.06%报5.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417912609","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417912609?lang=zh_cn&edition=full","pubTime":"2024-03-05 00:18","pubTimestamp":1709569083,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日00时18分，Allogene Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报5.19美元/股，成交量55.1833万股，换手率0.33%，振幅6.88%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305001803861db0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305001803861db0ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414880362","title":"Allogene Therapeutics Inc盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414880362","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414880362?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:32","pubTimestamp":1709044329,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时32分，Allogene Therapeutics Inc股票出现波动，股价快速拉升5.40%。截至发稿，该股报4.88美元/股，成交量4.676万股，换手率0.03%，振幅2.59%。Allogene Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为309.18%、83.77%、29.60%，振幅较大的相关个股有Viking Therapeutics Inc、Fate Therapeutics、Janux Therapeutics Inc，振幅分别为21.70%、17.84%、14.57%。Allogene Therapeutics Inc公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722321079151993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722321079151993&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414859247","title":"BUZZ-BMO 将 MediaAlpha 的评级上调至 \"跑赢大盘 \"后，该公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2414859247","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414859247?lang=zh_cn&edition=full","pubTime":"2024-02-27 03:27","pubTimestamp":1708975638,"startTime":"0","endTime":"0","summary":"    2月26日 - ** 在线客户获取平台 MediaAlpha   股价在午后交易中最多上涨11.8%，最后上涨7.3%，报21.49美元。** BMO将MAX的评级从 \"市场表现 \"上调至 \"跑赢大盘\"；将目标价从9美元上调至28美元，较上一交易日收盘价上涨28.5%。** 券商预计，由于汽车保险公司，尤其是 Progressive   ，将加大广告支出，超出分析师预期，2024-2025年期间与收入增长相关的MAX交易价值将大幅上升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413933647","title":"Allogene Therapeutics Inc盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413933647","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413933647?lang=zh_cn&edition=full","pubTime":"2024-02-23 23:55","pubTimestamp":1708703757,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日23时55分，Allogene Therapeutics Inc股票出现波动，股价大幅上涨5.05%。Allogene Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Maravai Lifesciences Hldgs Inc、Ocean Biomedical Inc涨幅较大，Enveric Biosciences Inc、Monopar Therapeutics Inc、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为349.97%、284.60%、138.31%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical Inc，振幅分别为80.39%、74.75%、68.26%。Allogene Therapeutics Inc公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232355577913ef49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232355577913ef49&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412869109","title":"Allogene Therapeutics Inc盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412869109","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412869109?lang=zh_cn&edition=full","pubTime":"2024-02-20 23:14","pubTimestamp":1708442062,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日23时14分，Allogene Therapeutics Inc股票出现异动，股价大幅跳水5.22%。截至发稿，该股报4.54美元/股，成交量23.0581万股，换手率0.14%，振幅5.22%。Allogene Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.17%。Allogene Therapeutics Inc公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402202314227912c81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402202314227912c81e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411368521","title":"Allogene Therapeutics Inc盘中异动 早盘快速下挫7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411368521","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411368521?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834677,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Allogene Therapeutics Inc股票出现异动，股价急速下跌7.66%。截至发稿，该股报4.58美元/股，成交量3.1655万股，换手率0.02%，振幅2.00%。Allogene Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为294.33%、80.14%、29.62%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Biovie Inc、Bioxcel Therapeutics Inc，振幅分别为12.41%、12.28%、10.76%。Allogene Therapeutics Inc公司简介：Allogene Therapeutics Inc是美国的临床阶段免疫肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223117878d1653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240213223117878d1653&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411338359","title":"美国研究综述-An2 Therapeutics、Par Technology、Trimble","url":"https://stock-news.laohu8.com/highlight/detail?id=2411338359","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2411338359?lang=zh_cn&edition=full","pubTime":"2024-02-13 15:10","pubTimestamp":1707808204,"startTime":"0","endTime":"0","summary":"    路透社2月13日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 An2 Therapeutics、Par Technology 和 Trimble。公司要闻 * An2 Therapeutics Inc   ：Leerink Partners将其评级从 \"跑赢大盘 \"下调至 \"市场表现\"。* Par Technology Corp   ：Benchmark给予其 \"持有 \"评级 * Trimble Inc   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* Cymabay Therapeutics Inc   ：B. Riley 将目标价从 29 美元上调至 32.5 美元 * Cymabay Therapeutics Inc   ：Jonestrading将其目标价从 \"买入 \"下调至 \"持有\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allstate.com","stockEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":-0.0159},{"period":"3month","weight":0.0809},{"period":"6month","weight":0.3156},{"period":"1year","weight":0.4696},{"period":"ytd","weight":0.215}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.0457},{"period":"6month","weight":0.1814},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"好事达保险公司于1992年11月5日根据特拉华州法律注册成立，作为Allstate Insurance Company的控股公司。其业务主要通过Allstate Insurance Company、Allstate Life Insurance Company和其他子公司（合称Allstate Corporation，“Allstate”）开展。好事达的宗旨是保护人们免受生命不确定性的影响，为他们的未来做好准备，使他们能够实现自己的希望和梦想。好事达主要在美国和加拿大从事财产和意外伤害保险业务。此外，好事达还为客户提供其他保护服务，如人寿、意外和健康保险，以及涵盖电子设备和个人身份的保护计划。","yearOnYearQuotes":[{"month":1,"riseRate":0.354839,"avgChangeRate":-0.013762},{"month":2,"riseRate":0.612903,"avgChangeRate":0.004047},{"month":3,"riseRate":0.580645,"avgChangeRate":0.021071},{"month":4,"riseRate":0.677419,"avgChangeRate":0.032445},{"month":5,"riseRate":0.516129,"avgChangeRate":0.012812},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.01662},{"month":7,"riseRate":0.580645,"avgChangeRate":0.011747},{"month":8,"riseRate":0.419355,"avgChangeRate":-0.009524},{"month":9,"riseRate":0.709677,"avgChangeRate":0.02465},{"month":10,"riseRate":0.580645,"avgChangeRate":0.009063},{"month":11,"riseRate":0.612903,"avgChangeRate":0.01391},{"month":12,"riseRate":0.677419,"avgChangeRate":0.023843}],"exchange":"NYSE","name":"好事达","nameEN":"Allstate"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"好事达(ALL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供好事达(ALL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"好事达,ALL,好事达股票,好事达股票老虎,好事达股票老虎国际,好事达行情,好事达股票行情,好事达股价,好事达股市,好事达股票价格,好事达股票交易,好事达股票购买,好事达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"好事达(ALL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供好事达(ALL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}